Business Summary: AdminMed is a medical device company developing a painless subcutaneous vaccine and drug injection device (“ADMINPEN”) based on advanced microneedle array technologies. ADMINPEN has an annual worldwide market potential of $2 billion.
Funding Stage: Functional Prototype; Industry: Drug Delivery
Clinical and Industry Need: Effective and painless delivery of vaccines and protein therapeutics, with a simple, mass produced and inexpensive device.
Solution: ADMINPEN™ device is based on a proprietary AdminPatch® microneedle array. The microneedles are formed from a standard metal film that allows scalable high volume and inexpensive manufacturing of the ADMINPEN. ADMINPEN device can be attached to any standard commercially available pen with a pre-filled drug cartridge or to any standard syringe. ADMINPEN is expected to be classified as a Class II medical device with a 510(k) regulatory approval route.